Medicaid policies boost oncology clinical trial enrollment for Black and Hispanic patients

By leveraging the unique strengths of each partner, the deal will expedite the development of anti-malarial treatment. Credit: Kitsawet Saethao/Shutterstock. Dr Reddy’s Laboratories, alongside its

Rifampin, ceftriaxone, or azithromycin are recommended as first-line alternatives to ciprofloxacin prophylaxis for close contacts of people with meningococcal disease in areas where the disease